Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Vaccines01:30

Cancer Vaccines

338
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
338
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Uncovering Electron-Transfer Mechanisms of Sulfur Anion Photosensitizers with Intramolecular Charge Transfer.

Journal of the American Chemical Society·2026
Same author

Tailored Biomaterials Induce Tertiary Lymphoid Structures for Boosting Cancer Immunotherapy.

ACS nano·2026
Same author

Quaternary Carbons from Amines and Acids.

Journal of the American Chemical Society·2026
Same author

FSTL3-Driven Cuproptosis Resistance and EPCs Promote OSCC Metastasis.

Journal of dental research·2026
Same author

Alternating Current-Promoted Copper Catalysis for the Construction of Alkynyl Thioethers.

The Journal of organic chemistry·2026
Same author

Multi-omics approaches reveal erythroid progenitor cell in cancer: from passive bystander to active player.

Oncogene·2026

相关实验视频

Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K

瘤向的催化免疫疗法

En-Li Yang1, Wu-Yin Wang1, Ying-Qi Liu1

  • 1The State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Science Center for Immunology and Metabolism, Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430079, China.

Advanced materials (Deerfield Beach, Fla.)
|December 16, 2024
PubMed
概括

先进的催化材料可以通过向瘤微环境 (TME) 来改善癌症免疫疗法. 本综述探讨了瘤向的催化材料及其提高癌症治疗疗效的机制.

关键词:
癌症免疫疗法免疫疗法催化材料是一种催化材料.有针对性的治疗.瘤微环境是一个微环境.

更多相关视频

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

639
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

相关实验视频

Last Updated: Jun 5, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.3K
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
07:55

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

639
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.4K

科学领域:

  • 生物医学工程 生物医学工程
  • 材料科学 材料科学 材料科学
  • 在瘤学瘤学.

背景情况:

  • 癌症免疫疗法看起来很有前途,但其反应率很低.
  • 免疫抑制性瘤微环境 (TME) 限制了治疗的有效性.
  • 向的催化材料提供了一个调节TME和增强免疫治疗的策略.

研究的目的:

  • 为增强癌症免疫疗法提供瘤向催化材料的全面概述.
  • 系统地审查进展,机制和准策略.
  • 讨论挑战和未来的临床翻译.

主要方法:

  • 关于瘤向催化材料的最新进展的文献综述.
  • 分析催化反应,材料结构和准机制.
  • 检查各种瘤特异性向策略.

主要成果:

  • 催化材料可以通过生物化学反应精确调节免疫抑制的TME.
  • 关键的准机制包括被动,生物活性,刺激反应和生物仿真方法.
  • 确定了多种瘤特异性向策略,包括对TME响应的方法.

结论:

  • 瘤向的催化材料对于提高催化免疫疗法的疗效至关重要.
  • 了解向机制对于最佳的治疗结果至关重要.
  • 解决临床翻译方面的挑战是下一代癌症治疗的关键.